Proto-Oncogene Proteins c-fos
"Proto-Oncogene Proteins c-fos" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cellular DNA-binding proteins encoded by the c-fos genes (GENES, FOS). They are involved in growth-related transcriptional control. c-fos combines with c-jun (PROTO-ONCOGENE PROTEINS C-JUN) to form a c-fos/c-jun heterodimer (TRANSCRIPTION FACTOR AP-1) that binds to the TRE (TPA-responsive element) in promoters of certain genes.
| Descriptor ID |
D016760
|
| MeSH Number(s) |
D12.776.260.108.765 D12.776.624.664.700.179 D12.776.660.760 D12.776.930.127.765
|
| Concept/Terms |
Proto-Oncogene Proteins c-fos- Proto-Oncogene Proteins c-fos
- Proto Oncogene Proteins c fos
- fos Proto-Oncogene Proteins
- fos Proto Oncogene Proteins
- Proto-Oncogene Proteins fos
- Proto Oncogene Proteins fos
- p55(c-fos)
- Proto-Oncogene Products c-fos
- Proto Oncogene Products c fos
- c-fos Proteins
- c fos Proteins
- p55 c-fos
- p55 c fos
|
Below are MeSH descriptors whose meaning is more general than "Proto-Oncogene Proteins c-fos".
Below are MeSH descriptors whose meaning is more specific than "Proto-Oncogene Proteins c-fos".
This graph shows the total number of publications written about "Proto-Oncogene Proteins c-fos" by people in this website by year, and whether "Proto-Oncogene Proteins c-fos" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 2 | 3 |
| 1994 | 0 | 1 | 1 |
| 1996 | 1 | 2 | 3 |
| 1997 | 1 | 0 | 1 |
| 1998 | 2 | 0 | 2 |
| 1999 | 0 | 2 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 3 | 4 |
| 2002 | 4 | 2 | 6 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 4 | 4 |
| 2005 | 1 | 3 | 4 |
| 2006 | 0 | 1 | 1 |
| 2007 | 2 | 2 | 4 |
| 2008 | 0 | 2 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 1 | 1 | 2 |
| 2012 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 3 | 4 | 7 |
| 2021 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proto-Oncogene Proteins c-fos" by people in Profiles.
-
The SWI/SNF chromatin remodeling assemblies BAF and PBAF differentially regulate cell cycle exit and cellular invasion in vivo. PLoS Genet. 2022 01; 18(1):e1009981.
-
Insulin-like growth factor-1 inhibits nitroglycerin-induced trigeminal activation of oxidative stress, calcitonin gene-related peptide and c-Fos expression. Neurosci Lett. 2021 04 23; 751:135809.
-
Epigenetic suppression of hippocampal calbindin-D28k by ?FosB drives seizure-related cognitive deficits. Nat Med. 2017 Nov; 23(11):1377-1383.
-
?FosB Regulates Gene Expression and Cognitive Dysfunction in a Mouse Model of Alzheimer's Disease. Cell Rep. 2017 07 11; 20(2):344-355.
-
Baicalin Alleviates Nitroglycerin-induced Migraine in Rats via the Trigeminovascular System. Phytother Res. 2017 Jun; 31(6):899-905.
-
The enhancement mechanism of wine-processed Radix Scutellaria on NTG-induced migraine rats. Biomed Pharmacother. 2017 Jul; 91:138-146.
-
Neurturin and a GLP-1 Analogue Act Synergistically to Alleviate Diabetes in Zucker Diabetic Fatty Rats. Diabetes. 2017 07; 66(7):2007-2018.
-
Analgesia effect of baicalein against NTG-induced migraine in rats. Biomed Pharmacother. 2017 Jun; 90:116-121.
-
Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia. Nat Med. 2017 Apr; 23(4):472-482.
-
Drug-Paired Contextual Stimuli Increase Dendritic Spine Dynamics in Select Nucleus Accumbens Neurons. Neuropsychopharmacology. 2016 07; 41(8):2178-87.